ESPINDI Trademark

Trademark Overview

On Wednesday, March 10, 2010, a trademark application was filed for ESPINDI with the United States Patent and Trademark Office. The USPTO has given the ESPINDI trademark a serial number of 77955531. The federal status of this trademark filing is ABANDONED - NO STATEMENT OF USE FILED as of Monday, October 14, 2013. This trademark is owned by Pfizer Inc.. The ESPINDI trademark is filed in the Pharmaceutical Products category with the following description:

Pharmaceutical preparations for the treatment of cardiovascular, central nervous system, endocrine, gastrointestinal, hematologic, immunological, infectious, inflammatory, menopausal, metabolic, musculoskeletal, neurological, oncological, ophthalmological, psychiatric, respiratory, urogenital, urological and viral diseases and disorders; pharmaceutical preparations for the treatment of erectile dysfunction, sexual dysfunction and pain; pharmaceutical preparations, namely, antifungal preparations, dermatological preparations, smoking cessation preparations; vaccines for human use
espindi

General Information

Serial Number77955531
Word MarkESPINDI
Filing DateWednesday, March 10, 2010
Status606 - ABANDONED - NO STATEMENT OF USE FILED
Status DateMonday, October 14, 2013
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, July 20, 2010

Trademark Statements

Goods and ServicesPharmaceutical preparations for the treatment of cardiovascular, central nervous system, endocrine, gastrointestinal, hematologic, immunological, infectious, inflammatory, menopausal, metabolic, musculoskeletal, neurological, oncological, ophthalmological, psychiatric, respiratory, urogenital, urological and viral diseases and disorders; pharmaceutical preparations for the treatment of erectile dysfunction, sexual dysfunction and pain; pharmaceutical preparations, namely, antifungal preparations, dermatological preparations, smoking cessation preparations; vaccines for human use

Classification Information

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateTuesday, March 16, 2010
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History

Party NamePfizer Inc.
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressNew York, NY 10017
Party NamePfizer Inc.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressNew York, NY 10017

Trademark Events

Event DateEvent Description
Tuesday, October 15, 2013ABANDONMENT NOTICE MAILED - NO USE STATEMENT FILED
Monday, October 14, 2013ABANDONMENT - NO USE STATEMENT FILED
Thursday, February 28, 2013NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Wednesday, February 27, 2013EXTENSION 5 GRANTED
Tuesday, February 26, 2013EXTENSION 5 FILED
Tuesday, February 26, 2013TEAS EXTENSION RECEIVED
Wednesday, February 13, 2013TEAS CHANGE OF CORRESPONDENCE RECEIVED
Tuesday, August 21, 2012NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Monday, August 20, 2012EXTENSION 4 GRANTED
Friday, August 17, 2012EXTENSION 4 FILED
Friday, August 17, 2012TEAS EXTENSION RECEIVED
Thursday, March 1, 2012NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Wednesday, February 29, 2012EXTENSION 3 GRANTED
Thursday, February 23, 2012EXTENSION 3 FILED
Thursday, February 23, 2012TEAS EXTENSION RECEIVED
Thursday, February 23, 2012TEAS WITHDRAWAL OF ATTORNEY RECEIVED-FIRM RETAINS
Wednesday, September 14, 2011NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Tuesday, September 13, 2011EXTENSION 2 GRANTED
Friday, September 9, 2011EXTENSION 2 FILED
Tuesday, September 13, 2011CASE ASSIGNED TO INTENT TO USE PARALEGAL
Friday, September 9, 2011TEAS EXTENSION RECEIVED
Friday, March 4, 2011NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Wednesday, March 2, 2011EXTENSION 1 GRANTED
Wednesday, March 2, 2011EXTENSION 1 FILED
Wednesday, March 2, 2011TEAS EXTENSION RECEIVED
Tuesday, September 14, 2010NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Tuesday, July 20, 2010OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, July 20, 2010PUBLISHED FOR OPPOSITION
Monday, June 14, 2010LAW OFFICE PUBLICATION REVIEW COMPLETED
Monday, June 14, 2010ASSIGNED TO LIE
Thursday, May 27, 2010APPROVED FOR PUB - PRINCIPAL REGISTER
Thursday, May 20, 2010ASSIGNED TO EXAMINER
Tuesday, March 16, 2010NEW APPLICATION OFFICE SUPPLIED DATA ENTERED IN TRAM
Saturday, March 13, 2010NEW APPLICATION ENTERED IN TRAM

Related Keywords

espindi preparations pharmaceutical dysfunction treatment disorders erectile diseases urological urogenital sexual